CRITICAL INNOVATIONS LLC
INGLEWOOD, CALIFORNIA 903023102
Contract Awards
20 awards found
DHA SMALL BUSINESS INNOVATION RESEARCH PROGRAM (SBIR) PHASE II, MEDICAL RESEARCH & DEVELOPMENT CONTRACT, FOR PROJECT TITLED "AID-TEX WEARABLE E-TEXTILE SYSTEM FOR CONTROL OF JUNCTIONAL AND EXTREMITY"
PHASE II SMALL BUSINESS INNOVATION RESEARCH (SBIR) TO IMPROVE TECHNOLOGIES OF SUCCOR COMBAT FOAM FOR PROTECTION AND TREATMENT OF DERMAL INJURIES CAUSED BY SULFUR MUSTARD.
SERVICES IAW SOW (BASE) - INC FUNDING
SERVICES IAW SOW (BASE) : P00001 REVISED MILESTONE TABLE, REVISED SOW ADDENDUM, AND INCREMENTAL FUNDING
DHA SBIR PH I TOPIC DHA242003 TITLE SUCCOR COMBAT FOAM FOR OPEN TRAUMATIC BRAIN INJURY MEDICAL R AND D
SERVICES IAW SOW (BASE)
DHA SBIR PH II H2S-0065 (MONTHS 1-23) MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR ARMY SBIR PHASE II PROPOSAL NO. HS2-0065 TITLED SUCCOR COMBAT FOAM FOR ADVANCED WOUND CARE OF TRAUMATIZED TISSUE.
DHA SBIR SEQUENTIAL PHASE II RESEARCH AND DEVELOPMENT CONTRACT, PROPOSAL TITLED: "DONALDSON DECOMPRESSION NEEDLE FOR AUTOMATED TREATMENT OF TENSION PNEUMOTHORAX"
DEFENSE HEALTH AGENCY SMALL BUSINESS INNOVATION RESEARCH PROGRAM, MEDICAL RESEARCH AND DEVELOPMENT CONTRACT AWARDED FROM PROPOSAL H241-002-0048, TITLE AID-TEX WEARABLE E-TEXTILE SYSTEM FOR CONTROL OF JUNCTIONAL AND EXTREMITY HEMORRHAGE
MODIFICATION P00002 EXERCISES OPTIONAL CONTRACT LINE ITEM 0002 FOR CONTINUED RESEARCH OF SUCCOR COMBAT FOAM FOR TREATMENT OF DERMAL INJURIES CAUSED BY SULFUR MUSTARD.
DHA SBIR SEQL PHASE II PROPOSAL H2S-0057 TITLE SUCCOR COMBAT FOAM FOR LARGE BURN WOUNDS MEDICAL R AND D LOG NUMBER 23000561
DEFENSE HEALTH AGENCY SMALL BUSINESS INNOVATION RESEARCH PROGRAM, AGENCY ANNOUNCEMENT 2022.4, DIRECT TO PHASE 2 MEDICAL RESEARCH AND DEVELOPMENT CONTRACT AWARDED FROM PROPOSAL NO. H2D-0130 TITLED, "EYE-AID SYSTEM FOR ACUTE OCULAR INJURIES"
PHASE II - BASE YEAR
SMALL BUSINESS INNOVATION RESEARCH (SBIR) PHASE I, ARMY TOPIC A234-004, "DIVER PERFORMANCE MONITORING SYSTEM"
PHASE II FOR A FULLY-QUALIFIED MANUFACTURING SYSTEM FOR THE AUTOMATED, ON-DEMAND, POINT-OF-USE PRODUCTION FOR SPACE FORCE END USERS REQUIRING A SOLUTION FOR PRODUCING QUALIFIED DEVICES FOR USE IN SPACE LOGISTICS SUPPORT.
DHA SBIR PHASE II -H2-0717 TOPIC DHA213-009 TITLE:RX- SHOOTER WEARABLE WOUND INFECTION TREATMENT DEVICE CRITICAL INNOVATIONS. MEDICAL R & D CONTRACT
PER SECTION 711 OF THE 2019 NDAA, USARMAA TRANSFERRED TO DHA 10/1/2022. MEDICAL RESEARCH AND DEVELOPMENT CONTRACT FOR ARMY SBIR PH II PROPOSAL NO A2-8980 TITLED SUCCOR COMBAT FOAM FOR ADVANCED WOUND CARE OF TRAUMATIZED TISSUE.
DHA SBIR PH II E RESEARCH AND DEVELOPMENT MEDICAL CONTRACT DHA SBIR MATCHING FUNDS AGREEMENT RECEIVED. PROPOSAL H2D-0002 TITLED SUCCOR COMBAT FOAM FOR LARGE BURN WOUNDS. TOPIC DHA201-D001.
DHA SBIR SEQ. PH II H2-0666 TITLE: PLEURAPATH THORACOSTOMY SYSTEM
DHA SBIR 19.1 PHASE II H2-0551 TITLED: DONALDSON DECOMPRESSION NEEDLE FOR AUTOMATED DIAGNOSIS AND TREATMENT OF TENSION PNEUMOTHORAX
Business Details
- UEI
- Q611FJPN1AK5
- CAGE Code
- 6WHE0
- Address
- 392 E BEACH AVE
INGLEWOOD, CA 903023102 - Congressional District
- CA-43
- Phone
- 3105006064
Parent Company
CRITICAL INNOVATIONS LLC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov